Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 10, Number 12, 2004

Book review

Favourites:
ADD

Preface [Hot Topic: Anti-Cancer Agents (Executive Editors: A.P. Kozikowski and M. Pellecchia)]
pp. ii-ii(1)
Authors: Pellecchia, Maurizio; Kozikowski, Alan P.

Favourites:
ADD

Review article

ABC Transporters and the Blood-Brain Barrier
pp. 1295-1312(18)
Author: Begley, David J.

Favourites:
ADD

Anti-HIV Drug Distribution to the Central Nervous System
pp. 1313-1324(12)
Author: Thomas, S. A.

Favourites:
ADD

Passage of VIP / PACAP / Secretin Family Across the Blood-Brain Barrier: Therapeutic Effects
pp. 1325-1340(16)
Authors: Dogrukol-Ak, Dilek; Tore, Fatma; Tuncel, Nese

Favourites:
ADD

Drug Delivery Systems for Brain Tumor Therapy
pp. 1341-1353(13)
Authors: Rautioa, Jarkko; Chikhale, Prashant J.

Favourites:
ADD

New Technologies for Drug Delivery Across the Blood Brain Barrier
pp. 1355-1363(9)
Authors: Kabanov, A. V.; Batrakova, E. V.

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Anticancer Agents: Tumor Cell Growth Inhibitory Activity and Binary QSAR Analysis
pp. 1399-1415(17)
Authors: Ren, Steven S.; Lien, Eric J.

Favourites:
ADD

Chemistry and Biology of Curacin A
pp. 1417-1437(21)
Authors: Wipf, Peter; Reeves, Jonathan T.; Day, Billy W.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content